Translate to...

EU in talks with Moderna, BioNtech, CureVac to secure possible COVID vaccines

EU in talks with Moderna, BioNtech, CureVac to secure possible COVID vaccines

The talks follow a deal reached in June by four EU states with AstraZeneca for the upfront purchase of 400 million doses of its potential COVID-19 vaccine, in principle available to all 27 EU nations.